V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160011803 | 160005618 | 1.76 | 74.6 | Curative (C) | 2017-04-27 | 2017-05-08 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101108280 |
| 160011806 | 160005619 | null | 96.7 | Palliative (P) | 2017-11-05 | 2017-11-19 | EW EuroEwing 2012 Arm A VIDE | 02 | N | STS NON-RHABDO EPSSG 2005 IFOS DOX | 101491986 |
| 160011813 | 160005620 | null | 78 | Palliative (P) | null | 2018-07-06 | Cisplatin + Pemetrexed | Y | N | CISPLATIN + PEMETREXED | 101791097 |
| 160011814 | 160005621 | 1.83 | 68.95 | null | 2019-08-25 | 2019-08-26 | OCTREOTIDE | 02 | N | ABIRATERONE | 100499682 |
| 160011815 | 160005622 | 1.71 | 90.1 | Neo-adjuvant (N) | 2020-10-03 | 2020-10-26 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100639775 |
| 160011817 | 160005623 | 1.76 | 69 | Palliative (P) | 2018-05-29 | 2018-06-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100788363 |
| 160011820 | 160005624 | 1.62 | 53.8 | Curative (C) | 2016-07-30 | 2016-08-15 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100394227 |
| 160011821 | 160005625 | 0 | 0 | Neo-adjuvant (N) | 2017-11-30 | 2017-12-27 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | VIDE | 101616553 |
| 160011823 | 160005626 | 1.75 | 95.7 | Palliative (P) | 2016-05-09 | 2016-05-13 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100291168 |
| 160011825 | 160005627 | 1.71 | null | Neo-adjuvant (N) | 2016-09-09 | 2016-09-10 | CARBOPLATIN + PACLITAXEL | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101062809 |
| 160011826 | 160005628 | 1.78 | 90 | Palliative (P) | 2018-05-18 | 2018-06-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101126680 |
| 160011827 | 160005629 | 1.83 | 40 | Palliative (P) | 2018-12-01 | 2018-12-15 | OSIMERTINIB | 02 | N | VIDE | 101237860 |
| 160011828 | 160005630 | 1.7 | 42 | 02 | 2016-01-17 | 2016-01-24 | ATOMIC-MESO TRIAL | 02 | N | TRIAL UNSPECIFIED | 101077260 |
| 160011829 | 160005631 | 1.82 | 107 | Palliative (P) | 2017-01-31 | 2017-02-19 | Imatinib 400mg | 02 | Y | DOXORUBICIN + IFOSFAMIDE | 100823979 |
| 160011831 | 160005632 | 1.71 | 0 | Neo-adjuvant (N) | 2019-04-26 | 2019-05-16 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101659571 |
| 160011832 | 160005633 | 1.74 | 82 | Palliative (P) | 2019-04-04 | 2019-04-16 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100292451 |
| 160011835 | 160005634 | 1.75 | 78.2 | Palliative (P) | 2017-09-12 | 2017-09-19 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100600894 |
| 160011837 | 160005635 | 1.5 | 6.2 | Palliative (P) | 2018-01-07 | 2018-01-13 | EW EuroEwing 2012 Arm B VDC | Y | N | TRIAL UNSPECIFIED | 100905181 |
| 160011840 | 160005636 | null | 83.4 | null | 2017-03-14 | 2017-04-01 | Bevacizumab+Carbo+Pacliaxel | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101809954 |
| 160011841 | 160005637 | 1.64 | null | Palliative (P) | 2017-02-07 | 2017-02-28 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100953140 |
| 160011842 | 160005638 | 1.59 | 85 | null | 2019-10-10 | 2019-11-10 | ETOP 13-18 BEAT-meso Trial | 02 | N | ICON8B TRIAL | 100734650 |
| 160011843 | 160005639 | null | null | Palliative (P) | 2018-10-31 | 2018-11-13 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101855460 |
| 160011844 | 160005640 | 1.75 | 76 | null | null | 2019-03-09 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | null | ETOP 13-18 BEAT-MESO TRIAL | 100707875 |
| 160011846 | 160005641 | 1.66 | 57.1 | null | 2017-05-06 | 2017-05-22 | Vinorelbine (oral) | 02 | null | VIDE | 101320607 |
| 160011849 | 160005642 | 1.59 | 61.4 | Palliative (P) | null | 2020-01-17 | DACARBAZINE + DOXORUBICIN | null | N | ATOMIC-MESO TRIAL | 100611379 |
| 160011850 | 160005643 | 1.9 | 59.8 | Neo-adjuvant (N) | 2020-01-10 | 2020-01-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101054308 |
| 160011851 | 160005644 | null | 78.9 | null | 2019-04-15 | 2019-04-21 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101068255 |
| 160011853 | 160005645 | 0 | 68.2 | Curative (C) | 2018-06-11 | 2018-06-24 | EW EuroEwing 2012 Arm B VDC | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101790302 |
| 160011854 | 160005646 | 1.61 | 95.4 | Palliative (P) | 2016-12-24 | 2016-12-26 | Doxorubicin + Ifosfamide | N | N | DOXORUBICIN + IFOSFAMIDE | 101171446 |
| 160011855 | 160005647 | 1.81 | 111.4 | Neo-adjuvant (N) | 2016-10-10 | 2016-10-10 | DOXORUBICIN | 01 | N | DOXORUBICIN | 100261055 |
| 160011858 | 160005648 | 1.75 | 116.1 | Neo-adjuvant (N) | 2018-05-29 | 2018-06-19 | ETOP 13-18 BEAT-meso Trial | 02 | N | TRIAL UNSPECIFIED | 100211640 |
| 160011859 | 160005649 | 1.22 | null | null | 2016-12-30 | 2017-02-07 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101550719 |
| 160011860 | 160005650 | 1.7 | 80 | Neo-adjuvant (N) | 2019-10-20 | 2019-10-29 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100322357 |
| 160011861 | 160005651 | 1.66 | 51 | Palliative (P) | 2017-01-24 | 2017-02-02 | STS Rhabdomyosarco RMS 2005 IVADoVV | 01 | N | DOXORUBICIN | 101401112 |
| 160011863 | 160005652 | 1.78 | 76 | Palliative (P) | 2018-02-24 | 2018-03-01 | DOXORUBICIN + IFOSFAMIDE | 02 | N | BEP | 101254453 |
| 160011865 | 160005653 | 1.73 | 74.6 | null | 2018-05-01 | 2018-05-15 | IPILIMUMAB + NIVOLUMAB | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + OBINUTUZUMAB + VINCRISTINE | 100267955 |
| 160011868 | 160005654 | 1.64 | 57.5 | Curative (C) | 2018-03-05 | 2018-03-06 | STS Non-Rhabdo EpSSG 2005 VDCy | N | N | TRIAL UNSPECIFIED | 100767271 |
| 160011875 | 160005655 | 1.57 | 69.05 | Palliative (P) | 2020-07-30 | 2020-07-30 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PEMETREXED | 100543507 |
| 160011876 | 160005656 | 1.57 | 82 | Curative (C) | 2019-07-12 | 2019-07-12 | Cisplatin + Etoposide (3 day) | 01 | N | PACLITAXEL | 100691602 |
| 160011877 | 160005657 | 1.72 | 68.2 | null | 2018-10-08 | 2018-10-22 | Lenalidomide 25mg (Cycle 1 to 25) | N | N | LIPOSOMAL DOXORUBICIN | 100701304 |
| 160011881 | 160005658 | 1.61 | 72 | Neo-adjuvant (N) | 2018-04-21 | 2018-05-05 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100489993 |
| 160011883 | 160005659 | 1.73 | 47.6 | Curative (C) | 2016-01-20 | 2016-01-20 | Trial Unspecified | 02 | null | DOXORUBICIN + OLARATUMAB | 100726329 |
| 160011885 | 160005660 | 1.71 | 54 | Palliative (P) | 2018-11-19 | 2018-11-30 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100855560 |
| 160011886 | 160005661 | 1.85 | 63.2 | Palliative (P) | 2018-03-14 | 2018-03-18 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101327747 |
| 160011888 | 160005662 | 1.63 | 79 | Curative (C) | 2017-01-01 | 2017-01-15 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 100877810 |
| 160011892 | 160005663 | 1.67 | null | Palliative (P) | 2018-10-13 | 2018-10-18 | IVADo | 1 | N | PACLITAXEL | 100836342 |
| 160011893 | 160005664 | 1.5 | 65.3 | Palliative (P) | 2017-10-11 | 2017-10-11 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101856229 |
| 160011896 | 160005665 | 1.68 | 86 | null | 2017-11-03 | 2017-11-26 | Trial Unspecified | 1 | N | DOXORUBICIN + IFOSFAMIDE | 101692073 |
| 160011897 | 160005666 | 1.54 | null | Neo-adjuvant (N) | 2017-02-24 | 2017-03-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101166566 |
| 160011899 | 160005667 | 1.67 | 71 | Palliative (P) | 2018-09-11 | 2018-09-18 | null | 01 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100800755 |